Literature DB >> 26010769

A new point mutation in EPOR inducing a short deletion in congenital erythrocytosis.

Aurélie Chauveau1,2,3, Damien Luque Paz1,3, Lydie Lecucq1,4, Gérald Le Gac2,3,5, Cédric Le Maréchal2,3,5, Paul Gueguen2,3,5, Christian Berthou2,6, Valérie Ugo7,8,9.   

Abstract

Entities:  

Keywords:  erythrocytosis; erythropoietin receptor mutation; myeloproliferative disorder; polycythaemia

Mesh：

Substances：

Year:  2015        PMID： 26010769     DOI： 10.1111/bjh.13511

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Investigation and Management of Erythrocytosis.

Authors:  Mary Frances McMullin
Journal:  Curr Hematol Malig Rep       Date:  2016-10       Impact factor: 3.952

2.  New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis.

Authors:  Florence Pasquier; Caroline Marty; Thomas Balligand; Frédérique Verdier; Sarah Grosjean; Vitalina Gryshkova; Hana Raslova; Stefan N Constantinescu; Nicole Casadevall; William Vainchenker; Christine Bellanné-Chantelot; Isabelle Plo
Journal:  Haematologica       Date:  2017-12-21       Impact factor: 9.941

Review 3.  Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis.

Authors:  Danijela Vočanec; Tinkara Prijatelj; Nataša Debeljak; Tanja Kunej
Journal:  Int J Lab Hematol       Date:  2018-12-03       Impact factor: 2.877

4.  Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors.

Authors:  Yajing Zhang; Senyu Wang; Songtao Han; Yangchun Feng
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.